RYAN MICHAEL CHARLES (Chief Technology Officer) reported 1 transaction at KIROMIC BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/2/2021ACC: 0001104659-21-098784
Officer· Chief Technology Officer
Since Jul 2021
+82.18K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
82.18K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50.19K
Price / share
—
Trade value
—
% of position
New position
7/13/2021
0.00→50.19K
Total
Net shares
+50.19K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/13/2021 | J · J | +50.19K | — | — | New position | 0.00 | 50.19K |
| Total | +50.19K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
31.99K shares
Shares
+31.99K
Strike price
Held after
31.99K
Exercisable
—
7/12/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock31.99K shares | 7/12/2021 | J · J | +31.99K | — | 31.99K |